Thursday, Aug 13, 2020 | Last Update : 11:52 AM IST

140th Day Of Lockdown

Maharashtra53560136843518306 Tamil Nadu3086492506805159 Andhra Pradesh2445491547492203 Karnataka1886111055993398 Delhi1461341316574131 Uttar Pradesh126722767212120 West Bengal98459671202059 Bihar8274154139450 Telangana8075157586637 Gujarat71064542382652 Assam5883842326145 Rajasthan5249738235789 Odisha4592731785321 Haryana4163534781483 Madhya Pradesh3902529020996 Kerala3433121832109 Jammu and Kashmir2489717003472 Punjab2390315319586 Jharkhand185168998177 Chhatisgarh12148880996 Uttarakhand96326134125 Goa871259575 Tripura6161417641 Puducherry5382320187 Manipur3752204411 Himachal Pradesh3371218114 Nagaland30119738 Arunachal Pradesh223115923 Chandigarh1595100425 Meghalaya11154986 Sikkim9105101 Mizoram6203230

Remdesivir

India's cheapest remdesivir version launched by Zydus Cadila at Rs 2,800 per vial

The drug will be sold under the brand name Remdac to government and private hospitals treating COVID-19 patients

13 Aug 2020 11:01 AM

Maharashtra FDA to buy remdesivir from Gujarat firm

State FDA minister Rajendra Shingne said the government plans to publish the price and availability of the drugs online for transparency

26 Jul 2020 3:55 PM

Jubilant Generics gets DCGI nod to manufacture COVID-19 drug Remdesivir

On June 21, Hetero and Cipla and on July 2 Mylan were given permission to manufacture and market the drug on the same conditions

21 Jul 2020 10:01 AM

Seven held for selling Remdesivir injections at higher cost

The officials said that each vial of the injection was being sold at 30,000 instead of 4,500

20 Jul 2020 12:50 PM

Gilead starts testing inhaled version of remdesivir for COVID-19

Gilead also plans to start additional clinical trials to evaluate remdesivir when used in combination with anti-inflammatory medicines

09 Jul 2020 9:10 AM

ADVERTISEMENT

Mylan Pharma to launch remdesivir in India at Rs 4,800 per 100 mg vial

The drug will be launched under the brand name Desrem in India and will be available to patients later this month

07 Jul 2020 1:48 PM

Remdesivir gets conditional EU clearance to be used in severe COVID-19 patients

The move comes just days after Gilead allocated nearly all of its supply of remdesivir for the next three months to the US

05 Jul 2020 1:54 PM

Cipla to price remdesivir version for COVID-19 under Rs 5,000

Gilead said on Monday it is targeting remdesivir supply for more than 2 million COVID-19 patients by the end of the year.

24 Jun 2020 9:16 AM

Gilead Sciences to start trials of inhaled version of remdesivir

The FDA granted remdesivir an emergency use authorisation for the treatment of hospitalised patients with severe Covid-19

23 Jun 2020 3:47 PM

Dr Reddy's inks licensing pact with Gilead Sciences for Remdesivir

Gilead Sciences signed similar non-exclusive licensing agreements with Cipla, Hetero Labs, Jubilant Lifesciences, Mylan and Zydus Cadila

14 Jun 2020 9:59 AM

ADVERTISEMENT

Health ministry okays remdesivir for moderate cases, HCQ for early course of COVID-19

It also okayed off-label application of tocilizumab, a drug that modifies the immune system or its functioning, and convalescent plasma

13 Jun 2020 11:35 PM

India's drug regulator grants Gilead Sciences marketing authorisation for remdesivir

The approval process for remdesivir was accelerated in view of emergency situation and unmet need for medicines in light of covid19 outbreak

03 Jun 2020 11:57 AM

Despite FDA warning, Trump says he is taking hydroxychloroquine

The Food and Drug Administration has issued a warning about its use

19 May 2020 10:15 AM

Health groups want India to rescind Gilead drug patents

Advocacy groups want remdesivir to be distributed more fairly to coronavirus patients around the world.

15 May 2020 11:46 AM

Gilead ties up with 5 generic drugmakers in India, Pakistan for Covid19 drug supply

The licenses are royalty-free until the World Health Organization declares the end of the public health emergency regarding Covid-19

13 May 2020 8:44 AM

ADVERTISEMENT

US allows use of remdesivir to help virus recovery

No drugs are currently FDA-approved for treating the coronavirus, and remdesivir will still need formal approval

02 May 2020 11:02 AM

US to roll back social distancing guidelines from tomorrow

Trump hopes to hold mass campaign rallies in the coming months, even though experts say there is little hope of having a vaccine by then

30 Apr 2020 10:29 AM

WHO Solidarity trial testing antiviral drug remdesivir, as it could stop coronavirus from replicating

In an observational study, 68 per cent or two out of three patients after treatment with the drug did not require ventilator support

14 Apr 2020 1:51 PM

ADVERTISEMENT
ADVERTISEMENT